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Programed DNA mutagenesis events in the immunoglobulin (Ig) loci of developing B cells
utilize the common and conserved mechanism of protein ubiquitination for subsequent
proteasomal degradation to generate the required antigen-receptor diversity. Recombi-
nase proteins RAG1 and RAG2, necessary for V(D)J recombination, and activation-induced
cytidine deaminase, an essential mutator protein for catalyzing class switch recombination
and somatic hypermutation, are regulated by various ubiquitination events that affect pro-
tein stability and activity. Programed DNA breaks in the Ig loci can be identified by various
components of DNA repair pathways, also regulated by protein ubiquitination. Errors in the
ubiquitination pathways for any of the DNA double-strand break repair proteins can lead to
inefficient recombination and repair events, resulting in a compromised adaptive immune
system or development of cancer.
Keywords: RAG proteins, AID,V(D)J recombination, class switch recombination, somatic hypermutation, ubiquiti-
nation, DNA repair
INTRODUCTION
B cells are developmentally programed to undergo DNA double-
strand breaks (DSBs) in the immunoglobulin (Ig) locus as they
generate the antibody diversity required for adaptive immunity.
Immature B cells reside in the bone marrow and undergo V(D)J
recombination, using the DNA endonuclease activity of RAG1 and
RAG2, to rearrange multiple gene segments and select a V(D)J
exon in the immunoglobulin heavy chain (IgH) and a VJ exon in
the immunoglobulin light chain (IgL) loci (1–3). Following V(D)J
rearrangement, IgM+ B cells traverse to secondary organs (e.g.,
Peyer’s patches or the spleen) to undergo two additional DNA
alteration events, namely class switch recombination (CSR) and
somatic hypermutation (SHM), using the activity of the DNA
cytidine deaminase activation-induced cytidine deaminase (AID)
(4). CSR is a chromosomal rearrangement–deletion event requir-
ing single-strand breaks in close proximity to each other on both
DNA strands for selection of the particular antibody isotype the B
cell will produce (5). SHM is the incorporation of point mutations
in the recombined V(D)J exon of the IgH and IgL loci to increase
the affinity of the expressed antibody for its cognate antigen (6).
In this review, we discuss how DNA mutagenesis during V(D)J
recombination, CSR, and SHM is regulated by various protein
ubiquitination events.
Ubiquitination is a post-translation modification utilized as a
regulatory mechanism by cells. The process involves the sequential
actions of an ubiquitin-activating enzyme (E1), an ubiquitin-
conjugating enzyme (E2), and an ubiquitin ligase (E3) to cova-
lently attach ubiquitin to a lysine residue of the target protein.
Deemed initially to be merely a system to mark proteins for degra-
dation by the 26S proteasome, the diversity of ubiquitination and
downstream events has recently been increasingly appreciated,
reinforcing the possibility of an “ubiquitin code” as another layer
in the multifaceted landscape of molecular regulation [reviewed
in Ref. (7)].
RAG PROTEINS AND V(D)J RECOMBINATION
V(D)J recombination occurs in the IgH and IgL (comprised of Igκ
and Igλ) chains of B cells. At the IgH locus, V(D)J recombina-
tion first connects a diversity (D) to a joining (J) segment to form
a coding and a signal joint, followed by a second recombination
event to bring together a variable (V) segment to the preformed
DJ segment. IgL loci, on the other hand, do not contain D seg-
ments and are therefore subject to only one recombination event
to form a VJ coding segment. For T cells, β and δ TCR loci parallel
the IgH locus, first joining DJ segments before recombining to a V
segment; α and γ TCR are analogous to IgL loci (1–3).
Recombination activating genes 1 and 2, encoding proteins
RAG1 and RAG2 respectively, are necessary and sufficient for the
breaks and rearrangements during V(D)J recombination. RAG1
and RAG2, collectively referred to as RAG in this review, are
lymphoid-specific proteins that cleave and join DNA segments
during V(D)J recombination [reviewed in Ref. (8)]. The RAG
proteins specifically recognize recombination signal sequences
(RSSs) that flank each V, D, and J segment. RSSs are composed of
conserved heptamer and nonamer sequences separated by a non-
conserved gap of either 12 or 23 base pairs, named 12RSS and
23RSS, respectively. Upon recognition and binding of a 12RSS or
23RSS, the RAG proteins form a complex that then captures the
alternate 12RSS/RAG or 23RSS/RAG complex for synapsis to form
a paired complex [reviewed in Ref. (9)]. Synapsis occurs exclusively
between different RSS for efficient recombination, known as the
“12–23 rule.” After the paired complex is formed, the RAG pro-
teins nick and cleave 5′ of the RSS to produce a hairpin-closed
coding end and a blunt signal end. Subsequent processing by non-
homologous end joining (NHEJ) factors results in the final coding
and signal joints, completing the recombination of a D to a J seg-
ment, a V to a DJ, or a V to a J segment. Signal joints containing
the RSSs are excised, leaving coding joints as the operative DNA
in the cell. How RAG1 and RAG2 interact with each other and
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in what exact sequence remains to be determined. However, the
inherent ability of RAG to cause DNA breaks and recombination
is of concern, particularly if lesions occur outside of warranted
loci, namely IgH, IgL, or the TCR, engendering the possibility of
translocations with oncogenes and/or transformation of the cell
to a malignant state. Therefore, effective regulation of RAG1 and
RAG2 is crucial both for efficient V(D)J recombination to generate
the diversity in the adaptive immune system and for avoidance of
genomic instability.
RAG1 AS AN E3-UBIQUITIN LIGASE
RAG1 is the known catalytic component of the RAG complex,
responsible for DNA binding and cleavage during V(D)J recom-
bination [reviewed in Ref. (9)]. Core RAG1 is defined to include
all necessary regions required for V(D)J recombination activity.
Briefly, a well-defined nonamer-binding domain binds the non-
amer sequence of the RSS, as the name implies. A central region
(amino acids 528–760) includes a heptamer-binding domain and
RAG2 interacting region, which is thought to involve the zinc
finger region B (ZnB). Finally, three amino acids (D600, D708,
and E962), known as the DDE motif, are important for DNA
cleavage. Recently, interest in the significance of the non-core
regions of RAG1 has increased, especially with the observation
of the conserved N-terminal residues. Utilizing extrachromoso-
mal recombination substrates and deletion and mutation analysis,
the need for non-core RAG1 to enhance V(D)J recombination and
fidelity has been suggested (10). The ZnA region of RAG1 includes
an N-terminal RING domain that acts as an E3-ubiquitin ligase,
with the potential to ubiquitinate a panel of targets for various
downstream events (11–17), as well as the area which interacts
with histone 3 (see below). The ZnA region is able to homodimer-
ize, which may be significant for the E3-ubiquitin ligase activity of
RAG1 and/or its regulation (14).
Through an in vitro experiment, the N-terminal RING domain
of RAG1 has been shown to be capable of and necessary for
mono-ubiquitinating test substrate S-protein in the presence of
E2 enzymes UbcH10 or UbcH4 (11–17). Point mutations within
the RING region, as well as deletion of half of the RING domain,
strongly reduce the ubiquitination activity of the wild-type (WT)
construct. Poly-ubiquitination was also observed in the presence
of E2 UbcH5b, but in the absence of S-protein, suggesting that
RAG1 has an auto-ubiquitination capacity. Because the RING
domain of RAG1 is dispensable for V(D)J recombination activity,
it is possible to conclude that RAG1 has an alternate enzymatic
activity, though likely indirectly involved in V(D)J recombina-
tion. As noted above, RAG1 was identified as a potential E3-
ubiquitin ligase utilizing a synthetic assay. Subsequent studies
examining the RAG1 RING domain both in vitro and in vivo,
however, were able to identify specific target substrates ubiquiti-
nated by RAG1, and the nature of these ubiquitinations (11–16).
It appears that the RAG1 RING domain is capable of interacting
with multiple E2 ubiquitin-conjugating enzymes, with the spe-
cific E2 interaction possibly determining the subsequent ubiqui-
tinated substrate(s). Accordingly, possible regulatory mechanisms
for RAG1 and RAG2 activity and protein stabilization, as well as a
range of alternative downstream pathways, have tentatively been
identified.
Ubiquitinated proteins are most often recognized and degraded
by the 26S proteasome. However, RAG1’s unique RING domain
structure, coordinating three Zn ions as opposed to the stan-
dard two of canonical RING domains, along with its ability to
interact with a panel of E2 enzymes, suggest functions either
alternate to or in addition to protein degradation (14). These
alternative functions possibly are indirectly involved in V(D)J
recombination and/or RAG regulation. RAG1 can be ubiqui-
tinated in intact cells for subsequent degradation by the 26S
proteasome, as evidenced by ubiquitinated species only being
observed in a state of proteasome inhibition (11). Addition-
ally, through an in vitro ubiquitination and pull-down assay,
the RAG1 N-terminal region, containing the RING domain, Zn-
binding domain, and basic upstream region, was observed to
undergo auto-ubiquitination, specifically in the presence of E2
UbcH3/CDC34 (Figure 1C). In an experiment utilizing CH3-
ubiquitin, which is unable to form poly-ubiquitin chains, it
was shown that auto-ubiquitination of RAG1 primarily occurs
at one conserved lysine residue, K233. Poly-ubiquitination was
observed with WT ubiquitin, but does not necessarily depend
on K48-linkage as poly-ubiquitin chains were seen with a K48R
ubiquitin mutant. Finally, core RAG1 is more active than full-
length protein in vitro, suggesting the importance of RAG1 auto-
ubiquitination to potentially modulate its own turnover (11).
With the RING domain and its E3-ubiquitin ligase activity miss-
ing, auto-ubiquitination of RAG1 cannot occur which may lead
to the observed heightened activity of core RAG1, and possible
promiscuous over-activity.
Beyond auto-ubiquitination and subsequent degradation, the
RAG1 RING domain can interact with other E2 enzymes to ubiq-
uitinate substrates involved in V(D)J recombination. One such
substrate is histone H3 (13, 15). It was shown that the N-terminal
region of RAG1 directly interacts with histone H3 and an intact
RING domain is required for mono-ubiquitination of histone
H3 in vitro and in vivo (13). Through experiments using both
mutated and truncated proteins, it was determined that the N-
terminal domains of both RAG1 and endogenous histone H3
directly interact. Structural analysis reveals RING mutations do
not affect overall protein folding, just RAG1 activity. Furthermore,
extrachromosomal V(D)J recombination assays demonstrate that
point mutations within the RING domain of RAG1 cause deficient
DNA joining,but not cleavage,at the endogenous IgH locus in vivo.
It is interesting to note that patients with Omenn syndrome, a
condition that results in combined immune deficiencies includ-
ing reduced efficiency of V(D)J recombination, also harbor point
mutations in the RAG1 RING domain (18, 19). Though inefficient
V(D)J recombination from a RING domain mutation may be a
readout of disrupted regulation from RAG1 auto-ubiquitination,
ubiquitination of histone H3 may be an important factor dur-
ing V(D)J recombination to (a) tag the RSS breaks to recruit
DNA repair proteins, (b) destabilize the nucleosome or remodel
the chromatin for DNA accessibility for repair, (c) promote RAG
complex eviction to allow joining machinery to complete cod-
ing and signal joints, or (d) promote cell-cycle arrest (13). These
possibilities are not mutually exclusive, and all have the poten-
tial to provide alternative pathways to mediate effective V(D)J
recombination. Rather than one exclusive mechanism, it is likely a
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FIGURE 1 | RAG1 localization forV(D)J recombination. (A) RAG1 is
imported to the nucleus through nuclear pores upon KPNA2 binding to
RAG1 NLS signal, located in the core region. RAG1 is thought to be
retained within the nuclear lamina by binding KPNA1 upstream of the
RING domain. RAG1 accumulation in the nuclear lamina promotes
RAG1-dependent ubiquitination of KPNA1 in the presence of
(B) E2 UbcH2/Rad6 or UbcH5a, allowing simultaneous degradation of
KPNA1 by the 26S proteasome and release of RAG1 into the nucleus.
RAG1 is capable of E3-ubiquitin ligase activity through its RING domain in
the presence of a panel of E2 ubiquitin-conjugating enzymes. (C)Whereas
E2 UbcH3/CDC34 promotes auto-ubiquitination of RAG1 for protein
degradation, interaction with (D) E2 UbcH5a/5b enables RAG1 to bind with
VprBP, which then binds to the VDCR complex to recruit its E3 activity,
possibly to repair DNA breaks caused during V(D)J recombination.
(E) E2 UbcH2 allows RAG1 to recognize actively transcribed DNA that was
subject to DNA cleavage by core RAG1 by binding and ubiquitinating
histone H3, specifically acetyl-H3.3 S31p, thereby tagging the DNA region
for repair by NHEJ factors.
combination of the proposed models that is responsible for proper
V(D)J recombination.
Subsequent investigations describe histone variant H3.3 as the
target of RAG1 RING ubiquitination (15). Mutant RAG1 pro-
tein experiments and in vitro assays indicate binding between the
RAG1 RING domain and the N-terminus of histone H3.3. From
mass spectrometric analysis of H3 modifications, it is thought
that acetylation and phosphorylation of H3.3 (acetyl-H3.3 S31p)
are a mark of active chromosomes in mitotic cells, activate the
histone as a substrate for RAG1 RING-dependent ubiquitination,
and are upregulated during V(D)J recombination. Accordingly,
acetyl-H3.3 S31p could act as a tag for recombining loci catalyzed
by core RAG1 during V(D)J recombination (Figure 1E). Addition-
ally,H3.3 was shown to have multiple sites of mono-ubiquitination
in the presence of E2 UbcH2. It is possible that after DNA cleav-
age during V(D)J recombination, the RAG1 RING domain binds
acetyl-H3.3 S31p to target the break site and recruit DNA repair
complexes to complete the joining step and ensure faithful V(D)J
recombination. RAG1 was also identified as an E3-ubiquitin ligase
complex member, supporting the potential role of ubiquitinated
histones as marking breaks to recruit repair proteins (12). Evi-
dence for this role includes the observation that full length, but
not core, RAG1 with core or full-length RAG2 co-purifies with a
complex containing VprBP, DDB1, Cul4A, and Roc1 (VDCR com-
plex) in vitro, which is known to act as a recruitment scaffold for
repair proteins (Figure 1E).
Although there are multiple reports of RAG1 being capable
of E3-ubiquitin ligase activity, there are discrepancies as to with
which E2 enzyme the RAG1 RING domain interacts. Since the E3
enzyme of most ubiquitin reactions largely determines the spe-
cific substrate to be ubiquitinated, it is interesting to note that it
is the E2 enzyme instead that appears to target the downstream
ubiquitinated product in the context of E3 RAG1 (Figure 1). In
previously described studies, the presence of different E2 enzymes
results in different substrates of RAG1 RING. This observation
could be a consequence of differing experimental designs and the
lack of a reliable in vivo system. Alternatively, the results could
properly depict the broad range of potential proteins subject to
ubiquitination by the RAG1 RING E3 ligase activity for purposes
other than protein degradation.
As a potential model, upon RAG1 nuclear import (Figure 1A),
the interaction and ubiquitination of KPNA1 releases RAG1 from
the nuclear lamina with the assistance of E2 UbcH2/Rad6 or
UbcH5a (20) (Figure 1B). The freed nuclear RAG1 is then able
to auto-ubiquitinate in the presence of E2 UbcH3/CDC34, regu-
lating its own protein levels by marking itself for degradation (11)
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(Figure 1C). Alternatively, RAG1 can act with E2 UbcH2 to target
and ubiquitinate histone H3 of actively transcribing DNA for both
processing by V(D)J recombination and for tagging the cleaved
DNA to recruit proteins involved in DNA repair to promote robust
and efficient NHEJ (13) (Figure 1E). Simultaneously, RAG1 with
E2 UbcH5a/5b can interact with VprBP of the VDCR complex,
an E3-ubiquitin ligase complex, to recruit repair proteins dur-
ing V(D)J recombination (12) (Figure 1D). The proposed model
presents another level for the cell to regulate RAG1 by regulating
E2 enzymes available for use. For example, if E2 UbcH2/Rad6 and
UbcH5a are not available during S phase of the cell cycle, RAG1
would not be able to ubiquitinate KPNA1 and therefore unable
to release itself from the nuclear lamina to perform its catalytic
role. Regulation of these E2 enzymes prevents promiscuous RAG1
activity outside of appropriate V(D)J recombination events. Sim-
ilarly, the presence of E2 UbcH3/CDC34 or UbcH2 are important
in regulating RAG1 protein stabilization or recruiting repair pro-
teins for efficient V(D)J recombination, respectively. The second
activity of RAG1 as an E3-ubiquitin ligase, in addition to catalyz-
ing DNA breaks, provides alternative mechanisms in modulating
V(D)J recombination that include multiple pathways for RAG1
activity regulation.
REGULATION OF RAG2 BY UBIQUITINATION
Though the function remains rather elusive, RAG2, like RAG1,
has a defined core region (amino acids 1–383) located at the
N-terminal end and with core RAG1, is required for V(D)J
recombination [reviewed in Ref. (17)]. The RAG2 core is known to
be critical for DNA cleavage and enhances DNA binding and speci-
ficity of the RAG complex, probably through its interaction with
RAG1, as RAG2 itself has little or no DNA-binding activity. The
RAG2 non-core region includes a PHD domain that specifically
binds H3K4me3 to guide RAG2 to active chromatin and enhances
the catalytic activity of the RAG complex. An important charac-
teristic of RAG2 is its periodic accumulation and degradation in
relation to the cell cycle (21). RAG2 is phosphorylated at residue
Thr-490, located in the C-terminal non-core region, by the cell-
cycle-dependent protein cyclin A/CDK2. Cyclin A/CDK2 is upreg-
ulated at the G1/S phase transition and maintained through entry
into M phase. It is known that p27Kip1, a cyclin-dependent kinase
inhibitor, blocks the activity of cyclin A/CKD2, in effect stabilizing
nuclear RAG2 protein levels (21, 22). It is therefore hypothesized
that at the G1/S phase transition, p27Kip1 is degraded to allow
phosphorylation of RAG2 at Thr-490 by cyclin A/CDK2, leading
to RAG2 protein degradation and thereby regulating RAG2 protein
levels in a cell-cycle-dependent manner (Figure 2A).
Specifically, it was shown that RAG2 degradation is mediated
by ubiquitination and subsequent activity of the 26S protea-
some, as poly-ubiquitinated RAG2 species were observed upon
treatment with a specific 26S proteasome inhibitor (23). Further-
more, ubiquitination assays comparing full length, T490A mutant,
and C-terminal-deleted RAG2, with and without 26S proteasome
FIGURE 2 | Cell-cycle-dependent RAG2 localization forV(D)J
recombination. Periodic RAG2 accumulation is dependent on cyclin A/CKD2
activity. In the G1 cell-cycle phase, cyclin A/CKD2 is inhibited by p27Kip1 and
p21, and RAG2 protein is stable and abundant in the nucleus. Upon transition
into S phase, p27Kip1 and p21 are degraded, allowing (A) cyclin A/CKD2
activity to phosphorylate RAG2 at Thr-490 residue. This phosphorylation event
triggers (B) nuclear export of RAG2 where it can (C) bind Skp2 in the
cytoplasm to recruit the SCF complex. The SCF complex is a known
E3-ubiquitin ligase complex that (D) ubiquitinates RAG2 for (E) rapid
degradation by the 26S proteasome. This model explains the observed
periodic accumulation of RAG2 during G1, coinciding proper cell-cycle activity
for efficient V(D)J recombination.
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inhibition, suggest that sites for ubiquitin ligase interaction and
ubiquitination are located at the N-terminal region of RAG2.
Though the C-terminal region was observed to be inhibitory
to ubiquitination and degradation of RAG2, phosphorylation of
the Thr-490 residue abrogates this C-terminal inhibitory activ-
ity. These findings demonstrate self-regulatory functions of RAG2
through interactions of different regions of the protein. As alluded
to earlier, it was observed that RAG2 localizes in both the cyto-
plasm and the nucleus, and this subcellular localization is cell-cycle
dependent. Western blot analysis shows cytoplasmic RAG2 is less
stable than nuclear RAG2 (23). Along with active p27Kip1, the C-
terminal region helps to retain RAG2 within the nucleus. However,
post-translational phosphorylation of Thr-490 of RAG2 seems
to abrogate the C-terminal inhibitory function, allowing nuclear
RAG2 export into the cytoplasm (Figure 2B).
Cytoplasmic localization renders RAG2 accessible for ubiquiti-
nation and degradation. It was observed that phosphorylated Thr-
490 of RAG2 is an interacting site for another cell-cycle regulator,
Skp2-SCF (24). Via biochemical fractionation, E2 Cdc34, com-
monly associated with the SCF family of E3-ubiquitin ligases, was
identified as stimulating RAG2 ubiquitination. Further biochemi-
cal assays determined Skp2-SCF as the specific E3-ubiquitin ligase
complex for RAG2 ubiquitination, with confirmation from sub-
sequent in vivo mutation and knock-down experiments. G1 and
S/G2/M phase cells collected from Skp2-deficient mice demon-
strated that the periodic accumulation of RAG2 is dependent on
Skp2, as RAG2 protein levels from S/G2/M phase were elevated
in Skp2-deficient mice. Other in vitro experiments confirmed
the dependence on the Skp2-SCF complex in regulating RAG2
protein with the cell cycle. Skp2 was also shown to bind Skp1
of the SCF complex, which recruits the complex’s E3 activity to
RAG2 for ubiquitination and degradation. The SCF complex pos-
sesses alternative roles for targeting other cell-cycle factors such
as p27Kip1 and p21 for degradation (Figures 2B,C). Interestingly,
both p27Kip1 and p21 are inhibitors of cyclin A/CDK2 and are
therefore negative regulators of RAG2 degradation. The impor-
tance of SCF E3-ubiquitin ligase activity is highlighted by the
range of target proteins, which all ultimately converge to regulate
the activity of RAG2 and permit proper V(D)J recombination.
The findings from experiments investigating RAG2 activity and
degradation have emphasized RAG2’s role in regulating V(D)J
recombination activity to appropriate phases of the cell cycle.
DNA breaks during S phase are potentially harmful for cells
as they can lead to translocations and lymphomas when misre-
paired by homologous recombination (HR). It is therefore crucial
to limit V(D)J recombination activity within the G1 phase; the
restriction appears to be controlled by RAG2 localization and sta-
bilization. RAG2 nuclear accumulation is only observed during
G1, presumably because upon transition to S phase, p27Kip1 is
degraded, relieving suppression of cyclin A/CDK2 activity and
permitting phosphorylation of RAG2 at Thr-490 (21, 22). The
phosphorylation at Thr-490 allows for nuclear export where the
phosphorylated residue interacts with Skp2 to recruit the E3-
ubiquitin ligase activity of the SCF complex (24). Ubiquitination
of RAG2 allows for rapid degradation of the protein upon entering
S phase, thereby halting any potential off-target activities of RAG
(Figure 2).
The periodic accumulation and degradation of RAG2 has
significant implications for V(D)J recombination activity. Since
RAG2 together with RAG1 is required for catalysis of V(D)J recom-
bination events, its nuclear retention during G1 is important.
However, upon S phase entry, RAG2 is rapidly degraded to pre-
vent non-specific DNA cleavage events. Without RAG2, RAG1
can remain bound to DNA where its RING E3-ubiquitin ligase
activity can ubiquitinate histone H3 and/or VprBP, as discussed
earlier. Though RAG1 is catalytically compromised in the absence
of RAG2 for V(D)J recombination activity, it still retains its E3-
ubiquitin ligase activity. This proves significant as ubiquitination
of H3.3 possibly tags DNA for repair while ubiquitination of
VprBP is thought to recruit the E3 activity of the VDCR complex.
Together, degradation of RAG2 during the G1/S phase transi-
tion simultaneously halts V(D)J recombinase activity and recruits
NHEJ repair proteins to sites of DNA breaks for efficient and
productive V(D)J recombination.
AID-MEDIATED CLASS SWITCH RECOMBINATION AND
SOMATIC HYPERMUTATION
Upon completion of V(D)J recombination in the bone marrow,
immature IgM+ B cells migrate to secondary lymphoid tissues for
further DNA alterations events, namely CSR and SHM, which are
mediated by AID. Following antigen-dependent activation, ger-
minal center B-lymphocytes undergo CSR to generate antibodies
with different effector functions, and SHM to increase the affinity
of the antibody for its cognate epitopes, a process also known as
affinity maturation (6, 25, 26). The IgH locus has multiple constant
region genes (CH) that are preceded by G-rich switch sequences
(S) and subject to CSR. In mice, there are eight sets of CH exons
organized as 5′–V(D)J–Cµ–Cδ–Cγ3–Cγ1–Cγ2b–Cγ2a–Cε–Cα–
3′, and each S sequence has its own cognate promoter that is
influenced by enhancer elements, such as the 3′ regulatory region
enhancer (3′ RR) (5). This allows for transcription of stimulated
B cells at Sµ and another S sequence, such as Sγ1, Sγ3, Sε, or
Sα (Cδ lacks an upstream switch sequence), resulting in selec-
tion of a constant region that now encodes IgG1, IgG3, IgE, or
IgA, respectively. Transcription-dependent generation of a DNA
DSB mediated by AID at the donor Sµ sequence and downstream
acceptor switch sequence leads to a recombination–deletion event
that removes the intermediate sequences and propagates both
Sdonor–Sacceptor synapsis and catalysis of CSR [reviewed in Ref.
(1, 4)]. Additionally, B cells carry out SHM by introducing muta-
tions, also catalyzed by AID, in the variable regions of the IgH
and IgL loci, which, when synthesized, are in physical contact
with the antigen during an immune challenge. The mutations in
these segments occur at a frequency much higher than in other
regions of the genome. The mutations are initiated at RGYW
motifs by AID and spread as a consequence of downstream events
orchestrated by the mismatch repair (MMR) and base excision
repair (BER) pathways (27, 28) [reviewed in Ref. (6, 29, 30)].
Understanding the molecular mechanism by which transcription
within various regions of the Ig locus coordinates with the muta-
genic activity of AID to generate and regulate programed DNA
lesions has been a challenge. Comprehension is, however, neces-
sary to fully understand AID and its tumorigenic potential upon
misregulation.
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ACTIVATION-INDUCED CYTIDINE DEAMINASE AND PROTEIN
(IN)STABILITY THROUGH UBIQUITINATION
Activation-induced cytidine deaminase is a single-strand cytidine
deaminase that utilizes transcription-dependent mechanisms to
generate single-strand DNA (ssDNA) structures that allow muta-
genesis of target DNA substrates of B cells (31). Chromatin
immunoprecipitation (ChIP) of AID from CSR-stimulated B cells
followed by high throughput sequencing of AID-associated DNA
fragments (ChIP-seq) reveals that AID can bind various regions
of the B-cell genome, inside and outside the Ig loci, presenting
opportunities for genomic instability (32). Therefore, understand-
ing the physiological pattern and distribution of AID-generated
mutations at AID’s target sequences is vital. Changes in AID
mutation distributions at S regions can decrease CSR efficiency
and generate DSB intermediates causing oncogenic IgH translo-
cations while similar aberrant mutation patterns at the variable
regions during SHM can alter antibody specificity for antigen
(6, 33–36). Indeed, post-translation modifications and co-factors
of AID have been identified and proposed to affect its activity
through multiple mechanisms, such as (a) stimulation of AID’s
DNA deamination activity, (b) linking AID to the Ig transcrip-
tion machinery, (c) establishing a physiological DNA deamination
pattern on both strands of DNA, and (d) linking AID to the
downstream DNA repair machinery [reviewed in Ref. (4)]. Two
separate studies investigated the regulatory role of post-translation
AID ubiquitination during CSR and SHM (37, 38). Unlike RAG2,
AID protein stability is not associated with phases of the cell
cycle, but rather with subcellular localization. Utilizing expression
constructs, AID mutants, and pulse-chase experiments, the Rey-
naud group showed that in mouse B cells and 293T cells, nuclear
AID is subject to rapid turnover upon poly-ubiquitination (37).
Nuclear-restricted AID was shown to have enhanced mutagenic
activity in both Ig and non-Ig loci, demonstrating the impor-
tance of controlling AID off-target activity. As no specific lysine
residue was determined to be the target of ubiquitination, it
remains unclear whether several sites are poly-ubiquitinated or if
N-terminal residues of AID are targeted. This work highlights the
multilayer regulation of AID function, including protein stability
and turnover (37).
Since AID is known to promote oncogenic mutations in the
B-cell genome (4, 39, 40) and its protein levels are likely con-
trolled by ubiquitin-mediated degradation (37), it is crucial to
identify mechanisms of AID ubiquitination, specifically in the con-
text of the transcription complex. To this end, the Papavasiliou
group recently discovered that the RING E3 ligase RNF126, with
E2 UbcH5b, can mono-ubiquitinate AID in cell-free assay condi-
tions and in 293T cells (38). Though the functional implications
of RNF126-mediated AID ubiquitination were not investigated,
the authors provide several mechanistic insights concerning the
potential role of AID ubiquitination. Auto-ubiquitination and
ubiquitin binding, due to the presence of an N-terminal ubiquitin-
binding domain of RNF126, may prevent recruitment of PCNA
and translesion polymerase, which inhibits spreading of AID-
generated mutations. Alternatively, RNF126 could be involved
in regulating transcription initiation at promoters of AID target
genes, presenting important implications for AID targeting, dis-
cussed below. Better understanding of RNF126 in AID regulation
will be dependent upon generation of RNF126-deficient mouse
models (38).
UBIQUITINATION OF AID-ASSOCIATED RNA POLYMERASE II
Beyond post-translation modifications to regulate protein stabil-
ity, co-factors are also important for proper AID activity. AID
is proposed to bind the paused and/or stalled state of RNA
polymerase II (RNA pol II), consistent with its transcription-
dependent activity (4, 39, 40). Whereas “paused RNA pol II” is
bound to DNA and is positioned at DNA sequences proximal
to genic transcription start sites (TSSs) prior to entering tran-
scriptional elongation (41), “stalled RNA pol II” is positioned on
template DNA during RNA pol II elongation (42). RNA exosome
and Spt5 are co-factors of both RNA pol II and AID in B cells (43,
44). Though the 3′→ 5′ RNA exonuclease complex RNA exosome
is predominantly associated with the stalled RNA pol II complex,
Spt5 is associated with both paused and stalled RNA pol II com-
plexes (42). ChIP-seq data show AID-bound sequences have high
occupancy by RNA pol II molecules that are either in the elonga-
tion phase or in the paused or stalled state (43). Consistent with
these observations, RNA pol II is enriched at various regions of IgS
sequences, an AID target (45). The switch sequences are enriched
with AID and Spt5 (32, 43). These results present a role for the
transcription machinery in AID targeting and the importance
of regulating the transcription complex to prevent promiscuous
activity of AID. Below, we will discuss the role of ubiquitination
in regulating these processes.
Many AID-induced mutations occurring during CSR (36) or
SHM (46) are significantly downstream from the transcription
start sites of V genes or switch sequences (as opposed to 100 bps
downstream of TSS where RNA pol II promoter-proximal paus-
ing occurs). This downstream localization is also true for other
AID target genes (47). Thus, it is likely that elongation-stalled
RNA pol II is an adequate complex for recruitment of AID dur-
ing SHM and CSR. RNA exosome recruitment to stalled RNA
pol II requires the presence of a nascent RNA with a free 3′-end.
Stalled RNA pol II complexes occur during encounter with various
obstacles caused by (a) the presence of antisense transcription, (b)
secondary DNA structures including those caused by G-richness
on the non-template strand of S sequences, (c) variation in the
levels of elongation promoting chromatin modifications, and (d)
the presence of mutations or DNA lesions on the template DNA
(4, 39, 40). Resolution of the stalled complex includes mechanisms
of backtracking or early termination of the complex, which dis-
sociates the RNA from RNA pol II (41), or ubiquitin-mediated
destabilization of RNA pol II (42, 48). These mechanisms reveal a
free 3′-end RNA substrate for RNA exosome, a co-factor of AID.
Recently, it was shown that E3-ubiquitin ligase Nedd4 identi-
fies and ubiquitinates AID-associated RNA pol II (49). Through
immunoprecipitation experiments, AID was shown to interact
with RNA pol II, stalling factor Spt5, and RNA exosome. AID-
associated RNA pol II is poly-ubiquitinated in a Nedd4-dependent
fashion. B cells obtained from Nedd4-mutant mice demonstrate
increased stability of IgH germline transcripts that are expressed
from DNA switch sequences subject to AID mutations, indicating
that Nedd4 activity promotes processing of germline transcripts,
possibly by recruiting AID. Finally, B cells from Nedd4-mutant
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FIGURE 3 | Model for E3 ligase Nedd4 in mediating CSR. (A) During
transcription of the B-cell genome, RNA pol II in the elongation complex
encounters (B) a transcriptional block, such as secondary structures formed in
the G-rich switch regions of Ig genes. (C) Stalled RNA pol II exists in a
complex with interacting E3 ligase Nedd4, Spt4/5, RNA exosome, and AID.
RPA-associated AID targets the non-template DNA strand.
(D) K48-poly-ubiquitinated RNA pol II is released, relieving the 3′ end of the
RNA transcript available for RNA exosome degradation. The release of the
DNA/RNA hybrid allows AID to target both template and non-template
ssDNA (73).
mice are impaired in CSR and have a compromised mutation rate
in the 5′ Sµ sequence, an AID target. These observations high-
light the requirement of Nedd4 and its ubiquitin ligase activity
for proper AID-associated RNA pol II activity during antibody
diversification mechanisms (Figure 3).
The requirement of AID-associated RNA pol II ubiquitina-
tion has implications for AID targeting. First, ubiquitin-mediated
RNA pol II destabilization exposes the 3′ end of the RNA pol
II-associated nascent transcript for degradation by RNA exosome.
Nedd4 activity therefore could contribute toward the generation of
ssDNA substrates on both the template and non-template strands
of DNA for AID deamination by triggering RNA exosome activity
(Figure 3), possibly as an alternative mechanism to RNA pol II
backtracking. In addition to facilitating targeting of AID activity
to specific regions of the genome, Nedd4 may also prevent accu-
mulation of stalled RNA pol II at AID target regions in the B-cell
genome to prevent generation of aberrant DNA DSBs. Collision of
the stalled RNA pol II with replication machinery may be respon-
sible for DNA DSBs and chromosomal translocations. Whether
Nedd4 ubiquitination activity is required for RNA pol II desta-
bilization during SHM to promote mutations in variable region
genes or at oncogenic targets of AID is important to determine.
In addition to direct ubiquitination of AID to regulate its
nuclear localization and stability, ubiquitination also appears to
indirectly control AID targeting to its physiological DNA sub-
strates by facilitating AID-associated RNA pol II destabilization
to reveal substrates for RNA exosome, an AID co-factor. Protein
stability and specific targeting of nuclear AID are vital for effec-
tive CSR and SHM, and therefore regulation of both processes is
required to prevent off-target activity and genomic instability.
REPAIR OF DNA DOUBLE-STRAND BREAKS DURING B-CELL
DEVELOPMENT
As immature B cells are subject to programed DNA DSBs dur-
ing V(D)J recombination, CSR, and SHM during development,
appropriate repair of these DSBs is essential for proper B-cell mat-
uration and prevention of disease and oncogenesis. Importantly,
both RAG- and AID-induced DSBs depend on NHEJ, not HR,
for repair (1, 17). DSBs are initially recognized by the Ku70/Ku80
heterodimer to recruit kinase DNA-PK [reviewed in Ref. (50)].
Other DSB repair factors are then recruited, including XRCC4-
ligase IV, Pol µ, Pol λ, and TdT in lymphocytes. Phosphorylated
histone H2AX on Ser139 (γ H2AX) by DNA-PK is a well-known
mark for DNA damage and recruits MDC1 (mediator of DNA
damage checkpoint protein 1) via interaction with the BRCT
motif (51). Upon interacting with phosphorylated ATM through
its FHA domain, MDC1 both stabilizes the histone modification
and amplifies the γ H2AX signal (52). ATM then phosphory-
lates TQXF motifs of MDC1. It is at this point in the NHEJ
repair pathway that ubiquitination assumes its prominent role (53,
54). The initial recognition and recruitment of repair proteins to
DSBs is heavily dependent on phosphorylation events (e.g., kinase
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FIGURE 4 | RNF8- and RNF168-mediated repair of RAG- or
AID-induced DSBs. (A) DSBs from RAG or AID activity result in γH2AX
foci formation to recruit MDC1. (B) RNF8 recognizes ATM-dependent
phosphorylated MDC1 via its FHA domain. The RING domain of RNF8
then ubiquitinates DSB-associated chromatin. (C) RNF168 recognizes
ubiquitin-modified breaks via its MIU motif. RNF168 is recruited to DSB
sites and (D) extends the RNF8-mediated ubiquitin conjugates. The
RNF8/RNF168-dependent poly-ubiquitinated products are then recognized
for repair completion by BRCA1 through RAP80 for HR, or 53BP1 for
NHEJ.
activity and autophosphorylation of DNA-PK), but it is the down-
stream repair events that appear to be dependent on E3-ubiquitin
ligases (55).
ROLE OF E3 LIGASES RNF8 AND RNF168 DURING REPAIR OF DNA DSBs
At the crossroads between phosphorylation- and ubiquitin-
dependent events in DSB repair, phosphorylated MDC1 is recog-
nized by the E3 ligase RNF8 through its FHA (forkhead associated)
domain (56). Two separate groups described RNF8 binding to
MDC1 for ubiquitinating damaged-associated histones (57, 58).
Mailand et al. used a bioinformatics approach to panel motifs of
known DSB regulators to identify RNF8. Its function was tested
and it was observed to colocalize with γ H2AX at DSBs; colocal-
ization was abrogated in the absence of MDC1 (57). To further
characterize the relationship between RNF8 and MDC1, Mailand
used a combination of biochemical and real-time imaging tech-
niques to reveal the direct interaction of RNF8 and MDC1, which
requires the FHA domain and TQXF motif of RNF8 and MDC1,
respectively. Furthermore, RNF8 was shown to rapidly accumulate
at DSBs with the same kinetics as MDC1, preceding 53BP1 and
BRCA1 accumulation, suggesting that RNF8 functions upstream
of 53BP1 and BRCA1, factors involved with NHEJ and HR, respec-
tively. The second group, Huen et al., used a tagged-RNF8 con-
struct to biochemically determine its colocalization with γH2AX
and other known damage response proteins, such as MDC1 and
53BP1, to DSBs (58). Consistent with the previously described
study, RNF8 was shown to function downstream of γH2AX and
MDC1 recruitment and to interact directly with phosphorylated
TQXF motifs of MDC1 via its FHA domain. Both groups demon-
strate the necessity of both the FHA and RING domains for
complete RNF8 function. Importantly, the RING domain is capa-
ble of ubiquitin ligase activity on H2A (57) and H2AX (58) in
in vitro ubiquitination assays. In the presence of E2 Ubc13, RNF8
is capable of mono- and di-ubiquitinating H2AX. Taken together,
these findings present evidence for a functional link between RNF8
and H2A, possibly modifying histones to reveal buried substrates
necessary for downstream interactions by NHEJ repair proteins,
such as 53BP1.
Subsequent to the two previous studies, the Durocher group
showed that RNF8 also impairs 53BP1 focus formation (53).
Depleting RNF8 abrogated 53BP1 foci without disrupting MDC1
foci. Further investigation revealed that the N-terminal FHA
domain and C-terminal RING domain of RNF8 are both nec-
essary for 53BP1 focus formation as mutation in either domain
abolishes 53BP1 focus formation. This study highlights the signif-
icance of γH2AX- and MDC1-dependent RNF8 response to DSBs
in recruiting 53BP1 accumulation. However, direct interaction
between phosphorylated MDC1 and 53BP1 was not observed. This
is not unexpected, as 53BP1 is known to recognize H4K20me2,
suggesting an additional mediator exists downstream of RNF8 to
recruit 53BP1 (59).
Two groups utilizing similar genome-wide siRNA screens iden-
tified RNF168 as the additional mediator for 53BP1 focus forma-
tion (60, 61). Both groups confirmed RNF168 acts downstream
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of RNF8 in the repair pathway, as depletion of MDC1 and RNF8
abrogated RNF168 foci, but the foci were unaffected by deple-
tion of 53BP1 or BRCA1 (61). Furthermore, knock-down of
RNF168 results in RNF8 accumulation at DNA damage sites but
RNF8-dependent ubiquitinated chromatin is unstable, suggesting
transient activity of RNF8 that is stabilized by RNF168 (60). As
53BP1 foci were dependent on both the N-terminal RING and
two MIU (motif interacting with ubiquitin) domains of RNF168,
the RING domain of RNF168 was then tested for ubiquitin ligase
activity. In in vitro ubiquitin assays, RNF168 was indeed capable
of E3 activity, with direct interaction with Ubc13, the only known
E2 capable of catalyzing formation of K68-ubiquitin chains. Sub-
sequent experiments confirmed RNF168 specifically ubiquitinates
H2A type histones, including H2A and H2AX, with E2 Ubc13 to
form K63-ubiquitin chains. The poly-K63-ubiquitinated histones
were shown to be dependent on both RNF8 and RNF168. These
findings suggest a model whereby RNF8 is first recruited to sites
of DSBs via its FHA domain, recognizing phosphorylated TQXF
motifs of MDC1 (Figure 4B). RNF8 is then able to initiate the
ubiquitination of γH2AX to recruit RNF168 via its MIU domains
to promote K63-ubiquitin chain extension (60) (Figure 4C). In
this way RNF168 stabilizes and amplifies the transient ubiqui-
tin conjugate signals from RNF8 for recruitment of downstream
repair proteins (Figure 4D).
Though the sequential recruitment of RNF8 followed by
RNF168 is thought to mimic their sequential activity at DSBs for
repair (Figure 4), recent observations by Mattiroli et al. challenge
this model. In vitro assays confirm the ability of RNF8 and RNF168
to ubiquitinate free histone variants (62). However, in the presence
of purified nucleosomes, where the octamer surrounds DNA, only
RNF168 is capable of ubiquitinating H2A. Upon further investi-
gation, results suggest a mechanism whereby RNF168 recruitment
to sites of DSBs is RNF8-dependent, but RNF8-mediated ubiq-
uitin chain extension is dependent upon mono-ubiquitination
by RNF168. If this revised model holds, it will be interesting to
determine how RNF168 is initially recruited. Panier et al. suggest
RNF168 recruitment involves two “waves” of RNF168 accumu-
lation at DSBs, and describe the role of p97 in removing RNF8-
mediated ubiquitin conjugates to unmask H4K20me2 for 53BP1
interaction and recruitment (63).
RNF8- AND RNF168-DEPENDENT RECRUITMENT OF 53BP1 TO DSBs
Though the RNF8- and RNF168-dependent recruitment of repair
proteins to DSBs is well-documented, the mechanism by which
53BP1 recognizes its substrate, H4K20me2, remains unclear. As
mentioned above, RNF168 was shown to preferentially produce
K63-ubiquitin chains via its interaction with E2 Ubc13. How,
then, is 53BP1 able to recognize RNF8- and RNF168-modified
DSBs? Because of its effect on DNA repair and its important
role in various ubiquitin-dependent processes in the cell, the
ubiquitin-selective segregase p97 was investigated in relation to
RNF8 and RNF168 (64, 65). The accumulation of p97, and its
adaptor protein NPL4, at DSB sites was shown to be RNF8-
dependent but RNF168-independent (66). Moreover, RNF8 RING
domain and free nuclear ubiquitin must be present for p97
foci formation. In vivo co-affinity purification assays show p97
and RNF8 interact in a complex, with RNF8 directly binding
ubiquitin and p97 interacting with ubiquitinated moieties (67).
Real-time recruitment kinetics show p97 accumulation occurring
after MDC1 but before 53BP1, supporting observations of MDC1-
and RNF8-dependent recruitment for efficient downstream 53BP1
recruitment (66, 67). BRCA1 focus formation was not affected
by p97 depletion, confirming the specificity of p97 for 53BP1
recruitment (66).
Though 53BP1 recruitment is mediated by RNF168 ubiqui-
tin ligase activity, 53BP1 interacts with H4K20me2, not ubiq-
uitinated moieties (59). p97 was also observed to bind to and
regulate the turnover of RNF8-dependent K48-ubiquitin chains
(67). This suggests a mechanism by which RNF8 catalyzes K48-
ubiquitin chains to recruit p97 through its ubiquitin adaptor
UFD1–NPL4. The K48-ubiquitin conjugates are then removed
by the ATPase-driven segregation activity of p97, which causes
a rearrangement of the DSB-associated chromatin complex, pos-
sibly revealing buried H4K20me2, allowing interaction with and
recruitment of 53BP1 (67). This provides insight into the factors
directly mediating 53BP1 focus formation downstream of RNF8
activity for proper repair by NHEJ. Importantly, the polycomb
complex also interacts with H4K20me2 and with higher affinity
than 53BP1 (61). However, upon DNA damage and subsequent
γH2AX focus formation,L3MBTL1 (a polycomb complex protein)
is poly-K48-ubiquitinated with subsequent increased p97 interac-
tion and decreased H4K20me2 association (66). Taken together,
it is possible that RNF8 poly-ubiquitinates the H4K20me2-
associated polycomb complex at DSB-associated chromatin to
recruit p97–UFD1–NPL4 through direct binding of ubiquitin
moieties. The ATPase-driven segregation activity of p97 then
mediates the turnover of K48-ubiquitinated polycomb complex,
relieving H4K20me2 sites for recruitment of 53BP1. In this way,
p97 is essential for connecting the E3-ubiquitin ligase activities of
RNF8 to 53BP1 recruitment for NHEJ by revealing H4K20me2
binding sites for 53BP1.
53BP1 DIRECTS REPAIR TOWARD NHEJ AND AWAY FROM HR
In RNF168-deficient cells, 53BP1 foci are abolished and inefficient
repair of DSBs during V(D)J recombination and CSR are observed,
emphasizing the importance of RNF168 for 53BP1 recruitment
and repair of RAG- and AID-induced DSBs. Since V(D)J recom-
bination and CSR require repair of distal DNA breaks, the role of
53BP1 in promoting NHEJ has been investigated.
In 53BP1 knockout mice, long-range V(D)J recombination is
impaired, but short-range recombination between D–J segments is
not defective, supporting previous observations of increased fre-
quency of short-range intra-switch recombination during CSR
in the absence of 53BP1 (68). In addition to repair defects,
53BP1-deficient cells also exhibit end resection of unpaired V(D)J
recombination-induced coding ends (69). Inhibiting DNA end
resection is important for NHEJ-mediated repair of DSBs as the
resulting ssDNA presents microhomologies for repair by alterna-
tive end joining (A-EJ) and HR pathways. Taken together, 53BP1
recruitment to DSB sites presents alternative, though not mutually
exclusive, roles for repair during V(D)J recombination and CSR,
as discussed below.
In a distance-dependent manner, 53BP1 mediates synapsis of
distal DNA ends (Figure 5). It has been shown that 53BP1 is
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FIGURE 5 | 53BP1 recruitment to DSBs is dependent on RNF168.
Under normal physiological conditions, DSBs occur as a consequence
of RAG1/2 or AID activity. DSBs lead to recruitment of (A) RNF168 in
an γH2AX/MDC1/RNF8-dependent manner. RNF168 accumulation
and E3 ligase activity poly-ubiquitinates the DSB-associated
chromatin, revealing buried H4K20me2 sites for 53BP1 interaction,
possibly by rearranging chromatin structure. 53BP1 recruitment and
oligomers protect open DNA ends and mediate long-range
recombination and repair that occurs during V(D)J recombination and
CSR. (B) In the absence of RNF168, 53BP1 foci do not occur, leaving
DNA available for attack by nucleases for end resection. End resection
can then present microhomologies, resulting in A-EJ or
BRCA1-mediated HR. Both RNF168- and 53BP1-deficient cells result
in short-range recombination, translocations, and defective V(D)J
recombination and CSR. In this way, 53BP1 aids in directing repair
away from A-EJ or HR and toward NHEJ.
capable of joining breaks between 1.2 and 96 kb long, the range
of repair during rearrangement in V(D)J recombination and CSR
(70). This distance-dependent repair function corresponds to γ
H2AX spreading and is RNF8/RNF168-dependent. 53BP1 also has
been shown to associate with motor proteins, possibly to enhance
chromatin mobility during repair of distal DNA breaks (70, 71).
In a distance-independent manner, 53BP1 is important for DNA
end protection (71, 72). 53BP1 has been shown to block access of
DNA nucleases to DNA ends, possibly due to its ability to consti-
tutively interact with H4K20me2 (59, 70, 72). End protection is
vital for V(D)J recombination and CSR as it prevents formation of
ssDNA microhomologies that would permit repair by A-EJ or HR
repair pathways. In this way, 53BP1 directs the cell to repair DSBs
by NHEJ, shunning A-EJ or HR, and foci formation is dependent
upon RNF168 ubiquitin ligase activity (Figure 5).
CONCLUDING REMARKS
While programed DNA breaks in Ig loci during B-cell develop-
ment highlights the diverse repertoire of post-translation ubiqui-
tin modifications, ubiquitination processes conversely have shed
light on the vital aspects of protein regulation. Though normally
avoided, DNA breaks are essential during B-cell development
and for a functional adaptive immune system. Regulating the
proteins and repair pathways involved during these processes is
therefore of utmost importance. RAG and AID off-target activity
can be detrimental to the cell, introducing deleterious mutations
and/or translocations with oncogenes. E3 ligases and ubiquitina-
tion events have been shown in the context of RAG regulation,
AID activity and targeting, and recruitment of NHEJ repair pro-
teins. Ubiquitination of RAG and AID are proposed to be impor-
tant in restricting DNA damage activity at undesirable loci or
during incorrect cell-cycle phase. This demonstrates roles for ubiq-
uitin beyond canonical protein degradation. As ubiquitination is
involved in protein stabilization and accumulation, recruitment,
and co-factor binding, the cell is presented with another layer of
regulation, the ubiquitin code.
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